#Top Indian Pharma Companies Exporting to Mexico

[curetonbiotech]

India has established itself as one of the largest producers and exporters of pharmaceuticals worldwide, and Mexican markets are increasingly benefiting from this relationship. Indian pharmaceutical companies are known for providing high-quality, affordable medicines, which has made them valuable partners for Mexico’s healthcare sector. Indian pharma companies exporting to Mexico have played a crucial role in meeting the demand for affordable medicines in Latin America by delivering generic drugs, biosimilars, and over-the-counter products. This article highlights the top Indian pharma companies exporting to Mexico, their specialties, and the benefits they bring to Mexico’s healthcare system.

[exportimportdata13]

India's Export Landscape: Key Insights and Major Exporters

India has firmly established itself as a prominent player in the global export market, thanks to its diverse range of products and robust industrial base. This article explores the key highlights of India's export performance, major exporters, and top export companies, shedding light on the factors that drive the country's trade success.

Key Highlights of India's Export Performance

In October 2023, India saw a notable increase in its total exports, reaching USD 62.26 billion, a 9.43% rise from USD 56.90 billion in October 2022. This growth underscores the resilience and expansion of India's export sector amid global economic uncertainties. The fiscal year 2023–2024 marked a record total export value of USD 778.2 billion, with a slight increase of 0.04% from the previous year.

However, while the overall export value has grown, there was a 3% decrease in the export of goods, which fell to USD 437.1 billion. Conversely, exports of services saw a significant rise to USD 341.1 billion, highlighting a shift towards service-based exports.

Exports by Major Products:

Leather and Its Products

Petroleum Products

Gems and Jewelry

Automobiles, Equipment Parts, and Electronic Goods

Pharmaceutical Products

Organic and Inorganic Chemicals

Dairy Products

Handloom and Cotton Yarns

Top Exporting Countries:

China - USD 3,380 billion

United States - USD 2,019 billion

Germany - USD 1,688 billion

Netherlands - USD 934 billion

Japan - USD 798 billion

Italy - USD 717 billion

France - USD 676 billion

South Korea - USD 648 billion

Mexico - USD 593 billion

Canada - USD 569 billion

Major Exporters in India

India's export sector is characterized by a few key players who dominate various industries. Here’s a closer look at some of the major exporters:

1. Reliance Industries

Reliance Industries is the largest exporter in India, contributing to 15% of the country's total exports. The company excels in refining and petrochemicals, exporting petroleum products such as chemicals, polymers, and refined fuels. Its primary markets include Europe, Africa, and the Americas.

2. Tata Steel

Tata Steel stands out for its extensive steel production capacity, with an annual output of 35 million metric tons. The company's operations span from mining to manufacturing and marketing finished products. Tata Steel exports its products to a diverse range of markets, including the United States, Vietnam, Iraq, Afghanistan, Korea, Jordan, and Qatar.

3. Sun Pharmaceutical Industries

Sun Pharma is a global leader in pharmaceutical exports, specializing in APIs, generic drugs, and specialty medications. The company’s research-driven approach has expanded its reach to markets such as the USA, Belarus, Sri Lanka, and Myanmar.

4. Rajesh Exports Limited

Rajesh Exports is unique in its complete integration across the gold value chain, from retail branding to mining. Processing about 35% of the world’s gold, the company exports gold and jewelry to over 60 countries, including the USA, UK, Singapore, and UAE.

5. Tata Motors

Tata Motors is a leading automaker known for its diverse range of vehicles, including electric, commercial, and passenger vehicles. The company’s export markets include Latin America, Africa, the Middle East, and Vietnam.

6. Vardhaman Textiles

As the largest vertically integrated textile manufacturer in India, Vardhaman Textiles exports a significant portion of its yarn production. Its major markets are South Asia, Europe, Africa, Japan, and the United States.

7. International Lace Trade Center

The ILTC facilitates the export of handmade lace products, showcasing Indian handicrafts to the global market. The center supports artisans and exporters by providing various facilities for exhibitions and craft bazaars.

8. Bajaj International Private Limited

Bajaj International Pvt. Ltd., part of the Bajaj Group, exports a range of electronic products, including irons, gas stoves, ceiling fans, and room heaters.

9. Arvind Mills

Arvind Mills is renowned for its textiles and denim, including brands like Flying Machine and licensed international labels. The company operates retail chains such as Megamart, Unlimited, and Arvind Store.

10. Kiran Gems Private Limited

Kiran Gems is the world’s largest producer of natural diamonds, known for its advanced manufacturing systems and broad product variety. The company exports diamonds globally, setting industry standards in quality and precision.

Conclusion

India's export sector demonstrates impressive growth and diversity, driven by a range of industries and key players. From refined petroleum and high-quality textiles to pharmaceuticals and automobiles, India's global trade footprint continues to expand. The country’s top exporters play a crucial role in shaping its economic landscape, leveraging technological advancements and market diversification to maintain their competitive edge.

For businesses and individuals interested in exploring India's export opportunities, platforms like ExportImportData.in offer comprehensive insights and data to facilitate informed decision-making.

[ikrispharmaa]

Ikris Pharma Network | International pharmaceutical wholesaler

Ikris Pharma Network founded in 2014 and is based in Noida, India. We are one of the most reliable pharmaceutical companies for generic and branded medication (AstraZeneca, Pfizer, Sun Pharma etc.) supplies globally, making it a key player in the industry.

Ikris Pharma Network has a vast and wide range of 5000+ generic and branded drugs’ distribution services globally and is one of the top notch generic medicine suppliers. As a branded and generic medicine supplier, we specifically deal in all types of medicines i.e. tablet, capsules, liquid, topical, suppositories, drops, inhalers, injections, implants or patches etc.

Ikris Pharma Network offers to its clients (hospitals, dispensaries, patients, pharmacies) up to date pricing and inventory levels, order status. With Ikris Pharma Network, clients have access to direct reach to 5,000+ branded & generic medicine & health care products, and their pricing related deets and Simplified, intuitive, branded & generic drug ordering. 

In the industry of healthcare, we acknowledge that the one size usually does not fit all. And whether we're delivering pharmaceuticals or biopharmaceuticals, such as vaccines, we're completely aware that our patients depend on prompt as well as punctual delivery of their pharmaceutical products. We understand that our patients place trust in us to deliver for them. With Ikris Pharma Network, you can count on us to deliver for you.

Our efficiently optimised transportation and logistics services, large-scale global network, absolutely strict adherence to national and international compliance, and topmost or supreme end-to-end visibility allows/enables our clients’ supply chains with agility, balance, and speed to industry. 

Our experienced team is working relentlessly around the clock to ensure your precious and often life-saving shipments get to where they need to be - securely, at the appropriate and standard temperature, and on time.

From branded to Indian generic medicines, from RLD to Named Patient Program, Ikris Pharma Network delivers reliability for each customer across the industry. Have peace of mind in order to know that we have been delivering reliable solutions for our life science customers at the global level.

With proficient professionals, sophisticated processes, and impeccable reliability, it is our aspiration and liability to keep up to ensure our clients’ supply chains and businesses both succeed and thrive. 

We have assisted more than 50,000+ patients to date. We offer Validated and Customized solutions for cold chain products including vaccines We have Exported Indian Generic drugs to over 150+ nations including Romania, Brazil, China, South Africa, Italy, UK, Russia, Poland, Mexico, Latvia, etc.

[aprao22]

Top 10 Pharma companies

Top 10 pharmaceutical companies in the world

These are ranked by revenue and market capitalization:

1. Pfizer — $51.8 billion 2. Roche  — $50.1 billion 3. Novartis  — $47.45 billion                                                                                    4. Merck  — $46.9 billion 5. GlaxoSmithKline (GSK) — $43.6 billion 6. Johnson & Johnson (J&J) — $42.2 billion 7. AbbVie — $33.3 billion 8. Sanofi — $27.8 billion 9. Bristol-Myers Squibb — $26.2billion 10. AstraZeneca — $23.6 billion

1.Pfizer

Pfizer is an American multinational pharmaceutical corporation, headquartered in Manhattan. It develops and produces medicines and vaccines for a wide range including oncology, cardiology, neurology, immunology, and endocrinolog

2.Roche

Hoffmann-Roche AG is a Swiss multinational pharmaceutical company headquarters located in Basel, Switzerland.it operates two divisions: Pharmaceuticals and Diagnostics.

3.Novartis

Novartis AG is a Switzerland multinational pharmaceutical company headquarters located in Basel. It manufactures drugs clozapine, diclofenac, carbamazepine, valsartan, terbinafine, and others.

4.Merck

Merck & Co. is a German multinational pharmaceutical company incorporated in Jersey, United States of America.

5. GlaxoSmithKline ( GSK)

GlaxoSmithKline (GSK) is a British multinational pharmaceutical company headquartered in Brantford, England in 2000.

6. Johnson & Johnson (J&J)

Johnson & Johnson (J&J) is an American multinational company headquartered, New Jersey in 1886. It develops medical devices, pharmaceuticals, and consumer goods.

7. AbbVie

AbbVie is an American multinational corporation biopharmaceutical company founded in 2013. It operates as research-based pharmaceutical products, medical devices, diagnostic equipment, and nutrition products

8. Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, founded in 2013. It operates in the R&D, manufacturing, and pharmaceutical drugs' major therapeutic areas are the cardiovascular, central nervous system, diabetes, internal medicine, oncology, and vaccines.

9. Bristol-Myers Squibb

Bristol Myers Squibb is an American multinational pharmaceutical company, located in New York City. It manufactures pharmaceuticals, biologics, therapeutics, oncology, HIV, cardiovascular, diabetes, hepatitis, arthritis, and psychiatric diseases.

10. AstraZeneca 

AstraZeneca, is a Britain-Swedan multinational biopharmaceutical company, headquarters in England. It has manufactured major disease areas cancer, cardiovascular, respiratory, and inflammation. In 1999. they merged Swedish Astra AB and the British Zeneca Group.

Top 10 pharmaceutical companies in India

The top 10 pharmaceutical companies in India ranked by revenue and market capitalization:

Rank    Industry                        $Billions        ₹Crores

1           Sun Pharma                   10.3              75326.63

2           Dr. Reddy’s                      7.4               54,223.62

3           Divi’s                                6.2               45,023.67

4          Cipla                                 5.3               38,875.43

5          Aurobindo                         4.9               35,641.85

6          Torrent                              4.4               32054.46

7          Lupin                                 4.2               30362.52

8          Zydus Cadila                     3.5               25325.64

9          Abbott India                       3.1               22624.21

10        Alkem                                2.5                18584.54

India is the largest provider of generic medicines, holding a market share of 25% to worldwide supply by volume and meets 61% of the vaccine requirement around the world. Indian pharmaceutical companies also supply 81% of antiretroviral medications (HIV/AIDS) in the worldwide markets.

The international pharmaceutical market is anticipated to surpass USD 1.2Trillion by 2022. India is one most suitable states in this worldwide pharma market. India provides more than 55% of the worldwide purpose for different vaccines and 45% of the demand for generic medicines in the United States. India’s pharmaceuticals demanded to expand at 11% CAGR during 2023 to reach 33 Billion US dollars.

1. Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd is an Indian multinational pharmaceutical company founder Dilip Shanghvi in 1983, Vapi, Headquarters Goregaon, Mumbai, India, And Subsidiaries Ranbaxy Laboratories, etc...It produces and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India also the United States. Sun Pharma provides formulations in psychiatry, cardiology, dialectology, neurology, and gastroenterology. The company supplies APIs such as etodolac, clorazepate, carbamazepine, warfarin, and anti-cancer drugs, peptides, steroids, sex hormones, etc. Sun supplies more than 2000 formulations and also exports in various other countries. The main features of Sun Pharmaceuticals are research and development facilities and its own API’s

2. Dr. Reddy’s Laboratories Ltd

Dr. Reddy’s Laboratories Ltd is an Indian multinational pharmaceutical company founder Kallam Anji Reddy in 1984, Hyderabad, India. The company produces pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and other countries and more than 195 drugs, 65 APIs for drug, biotechnology products. DRL has six APIs(CTO)and four Formulations(FTO)manufacturing plants across India. Its main focus research and development centers are Integrated product development Organization(IPDO) and Custom Pharmaceutical Services(CPS) located in Hyderabad, India.

3.Divi’s Laboratories Ltd

Divis Laboratories Ltd is an Indian pharmaceutical company founder Murali Divi in 1990, Hyderabad, India. It manufactures APIs, Intermediates, and Nutraceutical ingredients. Divis Labs have three manufacturing units located at Chouttal, Hyderabad, Chippada, A. Andhra Pradesh, and 3 Research and development centers. The Company exports the products to the USA, Europe, Japan, South Africa, Australia, and the Philippines.

4. Cipla Ltd

Cipla is an Indian multinational pharmaceutical company founder Khwaja Abdul Hamied in 1935, Headquarters Mumbai, India, And supplies top-quality generic medicines in India The company supplies a wide range of medicines. It has got a prominent position in the Indian market ad global market and more than 150 countries. The company provides quality products worldwide received approvals from major regulatory agencies and more than 2000 formulations cover areas like neurology and nephrology. Cipla has a global focus on the important markets of India, the US, and South Africa.

5.Aurobindo Pharma Ltd

Aurobindo Pharma is an Indian pharmaceutical company founder Nityananda Reddy started operations in 1988 with a single unit manufacturing Synthetic Penicillin at Pondicherry after became a public company in 1992 headquartered in HITEC City, Hyderabad, India. the company has provided key therapeutics like cardiovascular, antiretrovirals, antibiotics, gastroenterology, anti-diabetics, anti-Allergics. The company exports products to more than 160 nations in the world. Aurobindo pharma has production, research, and development and Subsidiaries units are Novagen Pharma, AuroZymes Ltd, etc

6. Torrent Pharmaceuticals Ltd

Torrent Pharma an Indian pharmaceutical company founder Uttambhai NathalalMehta in 1959 Headquarters Ahmedabad, India. started as Trinity Laboratories Ltd, and renamed Torrent Pharmaceuticals Ltd. nowadays, it is ranked leaders in the therapeutic sector of the women’s health care, cardiovascular, CNS, gastrointestinal, diabetology, oncology, gynecology, and anti-infective. They have first-class manufacturing units, R & D facilities, and a prevalent international presence in more than 50 nations. The company had procured the Elder Pharma’s Indian company, Zyg Pharma, the API plant of Glochem Industries, Unichem’s Sikkim Plant, Bio-Pharm Inc, generic pharmaceuticals, etc.

7. Lupin Ltd

Lupin is a multinational pharmaceutical company founder Desh Bandhu Gupta in 1968 Mumbai, India a large range of products like Branded & Generic Formulations, Biotechnology Products, APIs, and manufacturing centers are across India, Japan, Brazil, Mexico, and the United States. Subsidiaries are Novel Laboratories, Polynova Industries, and GAVIS Pharmaceuticals. The company is in treatment areas of Non-Steroidal Anti-Inflammatory Drugs, Cardiovascular, Gynaecology, Asthma, Paediatric, Diabetology, Gastro-Intestinal, and Anti-Infective drugs, Anti-TB and Cephalosporins sectors. The company is moved around more than 100 countries. It supplies top quality medications.

8.Zydus Cadila Healthcare Ltd

Zydus Cadila is a Zydus Cadila, is a fully integrated Indian Pharmaceutical company founded by Ramanbhai B. Patel in 1952 in Ahmedabad, Gujarat India. It provides active pharmaceutical ingredients, formulations, and animal healthcare products to wellness products. The company’s research and development facilities are in Gujarat, Maharashtra, Goa, Himachal, and Sikkim also research units in the US and Brazil. It has 1400 researchers across 20 sites, working on medicines and exploring various ideas from NCEs to vaccines, bio-similar products. The company’s global business has regulated markets of the United States, Europe, South Africa, Latin America, and also 30 other national markets in the world.

9. Abbott Pharma India Ltd

Abbott India Limited is a Pharmaceutical company founder Dr. Wallace Calvin Abbott in 1944, Mumbai, India, and a subsidiary of Abbott Laboratories United States. It manufactures pharmaceutical drugs, therapeutics Women’s Health, Neurology, Thyroid, Gastroenterology, Anti-Infective, Diabetes, Urology, Pain, Vitamins, etc., and a plant at Verna, Goa. Abbott has to produce high-quality formulations, branded generic pharmaceuticals, diagnostics, medical devices, and nutrition.

10. Alkem Laboratories Ltd

Alkem Laboratories is a Pharmaceutical company founder Samprada Singh in 1973, Mumbai, India. It provides quality branded generics, generic medications, APIs, nutraceuticals in India, and more than 60 countries around the world. Alkem Laboratories has been ranked as the No.1 Anti-infective company in India for more than ten years also therapeutic segments of gastrointestinal, Vitamins, Minerals, Nutrients, and pain management.

[kennethresearch]

Global Bioinformatics Market, June 2021 Report On 2021 Industry Outlook, Current Status, Supply-Demand, Growth Opportunities and Top Players Analysis 2030

In a recently published report, Global Bioinformatics Market report for till 2030. The report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Global Bioinformatics Market products.

Get Sample Reports Here – https://www.kennethresearch.com/sample-request-10346904

It is also anticipated to grow on account of the growing demand for chemicals from the end users, backed by the increasing consumption of chemicals across different industries and the rising need for advanced chemicals. In India, the production of major chemicals and petrochemicals during the period 2020-2021 was close to 12000 thousand MT. Additionally, between the period 2015-16 and 2019-20, the production of the chemicals and petrochemicals in the nation grew at a CAGR of close to 6%.

Global Bioinformatics Market is valued at approximately USD 8.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 13.4% over the forecast period 2020-2027. Bioinformatics is a fusion of biology and information technology, which combines biological data with techniques for information storing, distribution, and assessment to support manifold areas of scientific research, involving biomedicine. Also, it is widely used in the management of biological data in the field of medical research and drug development. More often, bioinformatic utilizes computer software tools for database creation, data mining, data warehousing, data management, and communication networking. Thus, bioinformatics is gaining wide acceptance, as massive amount of data generated through this technique, which required for potential researched and medical purposes. Furthermore, the emergence of user-friendly and readily available bioinformatics software, including RasMol, AUTODOCK, BALL, etc., and surging utilization of these tools for precise and efficient evaluation of biomarkers discovery programs are likely to drive the market growth during the forecast years. Moreover, the surging amount of funds on drug discovery and development, coupled with the rising utility for protein sequencing and nucleic acid due to decreased sequencing costs are the few factors responsible for the high CAGR of the market during the forecast period. For instance, the Indian government initiative ‘Pharma Vision 2020’ has a goal for making India a major hub for drug discovery. To accomplish this initiative, the Indian government invest a worth of USD 942.8 million funds in 2020, to build three mega drug parks to drive sustainable cost-effectiveness. Similarly, in May 2020, the U.S. government signed a USD 354 million four-year contract with Phlow Corp., a new pharma company, to expand the production of drugs or medications in the country. This, in turn, is expected to strengthen the market growth all over the world. However, the lack of well-characterized standards and ordinary data formats for incorporation of data is the major factors restraining the market growth over the forecast period of 2020-2027. The regional analysis of the global Bioinformatics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in initiative on drug discovery and development & genomic research, along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the high adoption of IoT technologies in biopharma industry, coupled with the growing government funding on drug development in developing countries, such as China and India, would create lucrative growth prospects for the Bioinformatics market across the Asia-Pacific region. Major market player included in this report are: Agilent Technologies, Inc. Biomax Informatics AG Dnanexus, Inc. Genedata AG Intrexon Bioinformatics Germany GmbH Illumina, Inc. PerkinElmer, Inc. QIAGEN N.V. Seven Bridges Genomics, Inc. Thermo Fisher Scientific, Inc. The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Technology & Services: Knowledge Management Tools Bioinformatics Platforms Bioinformatics Services By Application: Metabolomics Molecular Phylogenetics Genomics Proteomics Others By End-User: Medical Bioinformatics Animal Bioinformatics Agriculture Bioinformatics Academics Others By Region: North America U.S. Canada Europe UK Germany France Spain Italy ROE Asia Pacific China India Japan Australia South Korea RoAPAC Latin America Brazil Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year – 2017, 2018 Base year – 2019 Forecast period – 2020 to 2027 Target Audience of the Global Bioinformatics Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors

Download Sample Reports Here – https://www.kennethresearch.com/sample-request-10346904

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook

Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook

Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook

Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email : Sales@kennethresearch.com

Phone: +1 313 462 0609

[gojennybaker]

Veterinary Vaccines Market 2020 Industry Research, Share, Trend, Global Industry Size, Price, Future Analysis, Regional Outlook to 2028 Research Report

Adroit Market Research has added a comprehensive global Veterinary Vaccines market research detailing all market drivers and a detailed analysis of the business vertical. The research report may become the most significant market in the world as it continues to play a prominent role in providing progressive impact on the global economy. The research report is a complete assessment of the market and contains the future trend, current growth drivers, detailed opinions, facts and verified industry market data.

The global veterinary vaccines market was valued at USD 8,190 .0million in 2019. The demand for veterinary vaccines has been increased due to rising incidence of zoonotic and livestock diseases.

Request for a sample copy of this report @ https://www.adroitmarketresearch.com/contacts/request-sample/1740

Our team's analysts have used advanced primary and secondary research techniques and tools to compile this report using top-down and bottom-up approaches and further analysis using analytical tools. The report offers effective guidelines and recommendations for players to build strong market positions. New players can also use this research to develop business strategies and understand future market challenges. We conduct a comprehensive competitive analysis that includes a detailed description of the company's leading players, a study of the nature and characteristics of the supplier market and other important research.

This detailed report also highlights key insights on the factors that drive the growth of the market as well key challenges that are expected to hamper the market growth in the forecast period. Keeping a view to provide a holistic market view, the report describes the market components such as product types and end users in details with explaining which component is expected to expand significantly and which region is emerging as the key potential destination of the Isoprene market. Moreover, it provides a critical assessment of the emerging competitive landscape of the manufacturers as the demand for the Isoprene is projected to increase substantially across the different regions.

Key players in global Veterinary Vaccines Market include: Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim, Elanco, Virbac Inc., Indian Immunological Limited, Heska Corp., Ceva, Bayer Pharma Ag, Phibro Animal Health Corporation, and Virbac SA among others.

The report serves as a requisite and highly dependable resource and investment guide to allow readers help in investigating versatile growth rendering conditions. In-depth analysis practices have also been followed to identify leading market players as well as contributing market participants who are willing to disrupt growth progress with multiple innovations. The report is designed to align with market participants’ aim to enable quick and steady penetration despite unfavorable market conditions.

Browse the complete report Along with TOC @ https://www.adroitmarketresearch.com/industry-reports/veterinary-vaccines-market

Key Segments of the Global Veterinary Vaccines Market  

Type Overview, 2019-2028 (USD Million)

 Bovine Vaccines

 Small Ruminant Vaccines

 Canine Vaccines

 Feline Vaccines

Technology Overview, 2019-2028 (USD Million)

Live Attenuated Vaccines

Inactivated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Other Vaccines

Disease Overview, 2019-2028 (USD Million)

 Bovine

 Small Ruminant

 Canine

 Feline

Regional Overview, 2019-2028 (USD Million)

 U.S.

 Canada

 Germany

 United Kingdom

 France

 Rest of Europe

 China

 Japan

 India

 Rest of Asia Pacific

 Brazil

 Mexico

 Rest of Latin America

Middle East & Africa

Important Facts about Veterinary Vaccines Market Report:

This research report encompasses Veterinary     Vaccines Market overview, market share, demand and supply ratio, supply     chain analysis, and import/export details.

The report has different approaches and procedures     endorsed by Key Market players that enable efficient business decisions.

The report offers information such as     production value, strategies adopted by market players and     products/services they provide.

Impacts of Advancements and COVID-19 on the market.

Amidst the COVID-19, few segments of the market have witnessed a disruption due to the gap in supply and demand which has impacted the growth of the Veterinary Vaccines market. Along with this, the latest advancements have changed the market dynamics of the market. This research report covers the wide-range analysis of the COVID-19 impact to the industry and gives out insights on the change in the market scenario due to the advancements.

The analysis objectives of the report are: 

To know the Global Veterinary Vaccines     Market size by pinpointing its sub-segments.

To study the important players and     analyse their growth plans.

To analyse the amount and value of the     Global Veterinary Vaccines Market, depending on key regions

To analyse the Global Veterinary Vaccines     Market concerning growth trends, prospects and also their participation in     the entire sector.

To examine the Global Veterinary Vaccines     Market size (volume & value) from the company, essential     regions/countries, products and application, background information.

Primary worldwide Global Veterinary     Vaccines Market manufacturing companies, to specify, clarify and analyse     the product sales amount, value and market share, market rivalry landscape,     SWOT analysis and development plans for future.

To examine competitive progress such as     expansions, arrangements, new product launches and acquisitions on the     market. 

Make an Enquiry About This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1740

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR(TM) (Diosmin/Hesperidin Tablets) Unique Natural Formula

MUMBAI, November 4, 2016 /PRNewswire/ —

Taj Pharma’s VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin – flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin – flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin – flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[ikrispharmaa]

Ikris Pharma Network founded in 2014 and is based in Noida, India. We are one of the most reliable pharmaceutical companies for generic and branded medication (AstraZeneca, Pfizer, Sun Pharma etc.) supplies globally, making it a key player in the industry.

Ikris Pharma Network has a vast and wide range of 5000+ generic and branded drugs’ distribution services globally and is one of the top notch generic medicine suppliers. As a branded and generic medicine supplier, we specifically deal in all types of medicines i.e. tablet, capsules, liquid, topical, suppositories, drops, inhalers, injections, implants or patches etc.

Ikris Pharma Network offers to its clients (hospitals, dispensaries, patients, pharmacies) up to date pricing and inventory levels, order status. With Ikris Pharma Network, clients have access to direct reach to 5,000+ branded & generic medicine & health care products, and their pricing related deets and Simplified, intuitive, branded & generic drug ordering. 

In the industry of healthcare, we acknowledge that the one size usually does not fit all. And whether we're delivering pharmaceuticals or biopharmaceuticals, such as vaccines, we're completely aware that our patients depend on prompt as well as punctual delivery of their pharmaceutical products. We understand that our patients place trust in us to deliver for them. With Ikris Pharma Network, you can count on us to deliver for you.

Our efficiently optimised transportation and logistics services, large-scale global network, absolutely strict adherence to national and international compliance, and topmost or supreme end-to-end visibility allows/enables our clients’ supply chains with agility, balance, and speed to industry. 

Our experienced team is working relentlessly around the clock to ensure your precious and often life-saving shipments get to where they need to be - securely, at the appropriate and standard temperature, and on time.

From branded to Indian generic medicines, from RLD to Named Patient Program, Ikris Pharma Network delivers reliability for each customer across the industry. Have peace of mind in order to know that we have been delivering reliable solutions for our life science customers at the global level.

With proficient professionals, sophisticated processes, and impeccable reliability, it is our aspiration and liability to keep up to ensure our clients’ supply chains and businesses both succeed and thrive. 

We have assisted more than 50,000+ patients to date. We offer Validated and Customized solutions for cold chain products including vaccines We have Exported Indian Generic drugs to over 150+ nations including Romania, Brazil, China, South Africa, Italy, UK, Russia, Poland, Mexico, Latvia, etc.

[thoughtfulenthusiastgoatee-blog]

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

Taj Pharma's VENOSTORâ„¢ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTORâ„¢ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

       (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500  mg  and 1000  mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin  

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid  500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a  global scale.

Other intended markets for this product  are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in  Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR™ (Diosmin/Hesperidin Tablets) Unique Natural Formula

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR™ (Diosmin/Hesperidin Tablets) Unique Natural Formula

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR(TM) (Diosmin/Hesperidin Tablets) Unique Natural Formula

By: PR Newswire Association LLC. - 04 Nov 2016

Back to overview list

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR™ (Diosmin/Hesperidin Tablets) Unique Natural Formula

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR(TM) (Diosmin/Hesperidin Tablets) Unique Natural Formula

MUMBAI, November 4, 2016 /PRNewswire/ —

Taj Pharma’s VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin – flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin – flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin – flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR™ (Diosmin/Hesperidin Tablets) Unique Natural Formula

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com